This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Restructuring at Neiman Marcus Group (A)
Harmon, Mike; Robles-Garcia, ClaudiaCase SGSB-F317A-EFinanceGeorge Kurtz founded CrowdStrike in 2011 to bring next-generation cybersecurity products to the marketplace. CrowdStrike used artificial intelligence to train its detection agent on evolving threats. This approach was revolutionary in an industry that had previously been fighting against previously detected and catalogued threats. CrowdStrike grew quickly, with impressive financial metrics. The company went public in 2019, and continued to evolv...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Oaktree: Pierre Foods Investment, Teaching Note
Ivashina, Victoria; Harmon, Mike; Shu, TerrenceTeaching Note HBS-220083-EFinanceTeaching note for case 219018.Starting at €0.00
-
Note on Restructuring Non-Debt Liabilities in the United States
Harmon, MikeCase SGSB-F318-EFinanceFinancial restructuring for a distressed firm and its significant counterparties is the process of “recontracting.” This involves significantly altering, replacing, or terminating key financial contracts for the purpose of rehabilitation. Most of these contracts, as of the date of such restructuring, typically relate to debt obligations with claim values that are known to the firm and to each of the counterparties who are involved in the restru...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Oaktree: Pierre Foods Investment
Ivashina, Victoria; Harmon, MikeCase HBS-219018-EFinanceThis case is a setting to discuss "loan to own" investment strategy that is often pursued by distressed investors. The aftermath of the 2007 financial crisis left many companies with poor liquidity and limited ability to obtain credit. One of these companies was Pierre Foods, a producer and distributor of processed and precooked protein products that had experienced several years of promising sales growth and held a leading market position. Despi...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Quiksilver Inc. and Oaktree Capital Management
Mugford, Kristin; Harmon, MikeCase HBS-219097-EFinanceStarting at €8.20